Yankui Li

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Haole Liu, Panpan Wei, Weilai Fu, Congcong Xia, Yankui Li, Kangli Tian, Yafeng Li, Daxin Cheng, Jiaying Sun, Yangwei Xu, Ming Lu, Boyu Xu, Yali Zhang, Rong Wang, Weirong Wang, Baohui Xu, Enqi Liu, Sihai Zhao
Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxidative medicine and cellular longevity 2022 (2022)
Hiroki Tanaka, Baohui Xu, Haojun Xuan, Yingbin Ge, Yan Wang, Yankui Li, Wei Wang, Jia Guo, Sihai Zhao, Keith J Glover, Xiaoya Zheng, Shuai Liu, Kazunori Inuzuka, Naoki Fujimura, Yuko Furusho, Toru Ikezoe, Takahiro Shoji, Lixin Wang, Weiguo Fu, Jianhua Huang, Naoki Unno, Ronald L Dalman
Recombinant Interleukin-19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms. Journal of the American Heart Association 10 (17) (2021)

Yankui Li.css-eqlu8i{font-size:small;padding-left:4px;}